Global Peripheral Intravascular Ultrasound (IVUS) Catheter Market Size By Type (IVUS as Stand-alone Procedure, Balloon Angioplasty with IVUS), By Application (Hospitals, Other), By Region, And Segment...

The Global Peripheral Intravascular Ultrasound (IVUS) Catheter Market was valued at USD 412 million in 2023 and is projected to reach USD 745 million by 2031, expanding at a CAGR of 7.5% during the forecast period from 2023 to 2031. This growth is driven by the increasing prevalence of peripheral artery disease (PAD), rising demand for minimally invasive diagnostic techniques, and the growing awareness of advanced imaging modalities in vascular assessment. IVUS catheters allow clinicians to obtain real-time, high-resolution cross-sectional images of blood vessels, enabling precise evaluation and treatment planning, particularly in interventional cardiology and vascular surgery.

Drivers:

1. Rising Incidence of Peripheral Artery Disease (PAD):

The growing elderly population and lifestyle-related risk factors such as diabetes, smoking, and obesity are contributing to an increase in PAD cases globally. IVUS catheters aid in better diagnosis and treatment of PAD, fueling market demand.

2. Technological Advancements in Catheter-Based Imaging:

Continuous innovations such as enhanced catheter flexibility, miniaturization, and integration with artificial intelligence for improved image interpretation are making IVUS a preferred diagnostic tool in vascular procedures.

3. Growth in Minimally Invasive Surgeries:

The trend toward minimally invasive procedures in vascular diagnostics and interventions is boosting the adoption of IVUS catheters, which provide detailed vessel imaging without the need for open surgery.

Restraints:

1. High Cost of IVUS Systems and Procedures:

The advanced technology involved in IVUS devices contributes to higher costs, limiting adoption in low-resource settings and smaller healthcare facilities.

2. Limited Skilled Professionals:

Effective utilization of IVUS imaging requires specialized training. The shortage of trained professionals in emerging markets remains a barrier to widespread adoption.

Opportunity:

1. Emerging Markets in Asia-Pacific and Latin America:

Rapid healthcare infrastructure development, increased healthcare spending, and rising disease awareness are expected to drive significant market opportunities in these regions.

2. Integration with AI and Machine Learning:

Combining IVUS imaging with AI can enhance diagnostic precision and reduce operator dependence, opening new frontiers in vascular diagnostics.

Market by System Type Insights:

Based on system type, the Mechanical IVUS Catheter segment dominated the market in 2023 due to its cost-effectiveness and wide clinical adoption. However, the Solid-State IVUS Catheter segment is expected to witness the fastest growth, driven by improved image resolution, lower catheter profile, and integration with advanced imaging software.

Market by End-use Insights:

In 2023, Hospitals held the largest market share due to the high volume of vascular procedures and availability of advanced imaging technologies. The Ambulatory Surgical Centers (ASCs) segment is anticipated to grow rapidly, driven by the rising preference for outpatient procedures and shorter recovery times.

Market by Regional Insights:

North America led the global IVUS catheter market in 2023, supported by well-established healthcare infrastructure, a high burden of cardiovascular diseases, and the early adoption of advanced medical imaging technologies. Asia-Pacific is projected to exhibit the fastest growth, fueled by increasing investments in healthcare, expanding patient base, and rising awareness of PAD diagnostics.

Competitive Scenario:

Key players operating in the Global Peripheral IVUS Catheter Market include Boston Scientific Corporation, Philips Healthcare, Infraredx, Inc., Conavi Medical Inc., Terumo Corporation, ACIST Medical Systems, Inc., and Abbott Laboratories. These companies are actively investing in product innovation, geographic expansion, and partnerships to strengthen their market position.

Recent Developments:

In 2023, Boston Scientific launched a next-generation solid-state IVUS catheter with enhanced imaging clarity for peripheral interventions.

In 2024, Philips Healthcare introduced an AI-enhanced IVUS interpretation software aimed at increasing diagnostic accuracy and procedural efficiency.

In 2025, Terumo Corporation expanded its catheter manufacturing facility in Japan to meet global demand for peripheral imaging solutions.

Scope of Work – Global Peripheral Intravascular Ultrasound (IVUS) Catheter Market

Report Metric Details

Market Si